What is the current stock price of Inozyme Pharma, Inc. (INZY)?

As of the latest market data, Inozyme Pharma, Inc. (INZY) is trading at $4.00. The stock has seen a gain of 0.25% today.

Does Inozyme Pharma, Inc. (INZY) pay a dividend?

Based on current data, Inozyme Pharma, Inc. does not have a confirmed active dividend policy.

What is the market cap of Inozyme Pharma, Inc.?

The current market capitalization of Inozyme Pharma, Inc. (INZY) is approximately unavailable.

INZY

Inozyme Pharma, Inc.·Healthcare

4.00

0.251%(+0.01)

Market Closed

Last Updated: — ET

52W L: $0.7252W H: $6.24

Company Profile

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2020-07-24

Beta

2.29

Websitewww.inozyme.com↗